Very excited to announce @EmbarcCollectiv's partnership with @MoffittNews and Speros by Moffitt, Moffitt’s massive $1.5 billion, 775-acre global patient care and research and innovation campus in Pasco County. Embarc Collective will lead Speros's new Florida Oncology and Radiopharmaceutical Growth Engine, or FORGE, startup incubation program, an innovative effort to bring new precision medicine solutions for cancer treatment across different modalities to market. “FORGE represents a transformational opportunity to position the Tampa Bay region at the forefront of one of the most promising advances in cancer care,” Speros President and Moffitt Chief Integration Officer Josh Carpenter (@jdcarpenter1) said. “By bringing together these regional partners, we are building the talent, infrastructure and innovation ecosystem needed to accelerate next-generation radiopharmaceutical therapies." The collaboration includes Moffitt Cancer Center, Speros by Moffitt, Embarc Collective, the @USouthFlorida, and Pasco-Hernando State College (@PHSCedu). The goal is “… to build an end-to-end radiopharmaceutical ecosystem that could generate 4,000 jobs and $2.6 billion in economic impact over the next decade” and establish the Tampa Bay region as a preeminent life sciences and healthcare hub for next-generation modalities that deliver best-in-class precision medicine. For more information about the new partnership, check out @anjelicamrubin's recent article in the @TBBJnewsroom here: bizjournals.com/tampabay/new…. Earlier this year, Embarc announced the addition of its first radiopharmaceutical tech startup to its community, TMAB Therapeutics, Inc, and named TMAB Therapeutics' founder and CEO, Dr. Tinashe Chandauka, as our first dedicated Healthcare and Life Sciences Coach (for more information, see embarccollective.com/resourc…). FORGE plans to launch an integrated theranostics center, a startup incubator with Embarc, imaging technologist training programs at PHSC and nuclear pharmacy opportunities at USF to allow companies to move from discovery and production to clinic use anchored at Speros. “We are excited to partner with Speros and Moffitt Cancer Center [to] support efforts to bring radiopharmaceutical and other precision medicine modalities to market through the Speros FORGE startup incubator," Embarc CEO Tim Holcomb said. "By bringing together world-class partners across research, health care, workforce development and entrepreneurship, we have an opportunity to build a globally competitive radiopharmaceutical and precision oncology hub right here in Tampa Bay." For more information about Embarc Collective, visit embarccollective.com/. #Startups #HighGrowth #VentureCapital #Founders #Technology #Innovation #EcosystemBuilders #StartupTB #StartupFL @FloridaC100 @FloridaEDC @FLChamber @FLACommerce @TB_Times @TampaEDC @TB_Chamber @PascoEDC @PascoChamber